Biolife stock.

View the latest BioLife Solutions Inc. (BLFS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Biolife stock. Things To Know About Biolife stock.

Girschweiler sold shares of BioLife stock valued at about $36 million to Casdin Capital LLC in a private transaction, the filing stated. His shares represented a 5% ownership of the BioLife.BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ...Find the latest GasLog Partners LP (GLOP-PC) stock quote, history, news and other vital information to help you with your stock trading and investing.Biolife Solutions story: Exercise or conversion by Aby Mathew of 8854 shares of Biolife Solutions subject to Rule 16b 3 and other headlines for Biolife SolutionsDec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking.

The estimated total pay for a Quality Manager at Biolife Plasma Services is $86,794 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. ... Additional pay could include bonus, stock, commission, profit sharing or tips. …

Historical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of December 01, 2023 is 13.25.. The all-time high BioLife Solutions stock closing price was 140.00 on December 15, 1992.; The BioLife Solutions 52-week high stock price is 26.89, which is 102.9% …Web2K Salaries (for 270 job titles) • Updated Nov 25, 2023. How much do Biolife Plasma Services employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Our model gets smarter over time as more people ...

Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings.Jan 6, 2023 · The stock seems fairly valued at the moment according to my valuation model. It’s trading around 20% below my intrinsic value, which means if you buy BioLife Solutions today, you’d be paying a ... BioLife Solutions Debt to Equity is currently at 0.06%. Debt to Equity is calculated by dividing the Total Debt of BioLife Solutions by its Equity. If the debt exceeds equity of BioLife. then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of …Aug 8, 2023 · BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $1.71 per share a year ago.

We are revolutionizing regenerative medicine, biobanking and drug discovery by increasing the viability of biologics. BioLife Solutions is a class-defining cell and gene therapy bioproduction tools and services company. Our solutions give life science companies and clinical researchers significant improvement in shelf life and post-preservation ...

1. Organization and significant accounting policies Business BioLife Solutions, Inc. (“BioLife”, “us”, “we”, “our”, or the “Company”) is a developer, manufacturer, and supplier of a portfolio of bioproduction tools and services including proprietary biopreservation media, automated cell processing fill machines, closed system cryogenic …Web

Nov 8, 2023 · Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Biolife Solutions share forecasts, stock quote and buy / sell signals below. According to present data Biolife Solutions's BLFS shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Step 3: Place a buy order. After identifying a stock or ETF you want to add to your portfolio, place a buy order through your brokerage account. While most brokers offer a wide range of order types, the two most common orders you'll use to buy and sell growth stocks are market orders and limit orders.Sexton's 2021 revenue contribution is expected to be approximately $2 million, based on an anticipated closing date of September 1st. BioLife 2021 total revenue is expected to be in a range of ...WebHENDERSON, NV, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTC: BLFE) (the “Company” or “BioLife”), announced today that... OTC.VN : 0.345 (unch) BLFE : 0.0001 (unch) BioLife Sciences Inc. (OTC: Markets: BLFE) Announced Today that the Company has Introduced Copper Infused Gardening Gloves to its Newly ...BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.

BUFFALO GROVE, Ill., Dec. 31, 2021 (GLOBE NEWSWIRE) — BIOLIFE4D Corporation today announced that it intends to submit a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission in early 2022 for a proposed underwritten public offering of its common stock. The number of shares of common stock to be sold…See the latest BioLife Solutions Inc stock price (BLFS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.BLFE | Complete BioLife Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.WebBioLife Solutions, Inc. (NASDAQ:BLFS) Major Shareholder Casdin Partners Master Fund, L Acquires 58,465 Shares marketbeat.com - August 11 at 7:16 PM: Analysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Synlogic (SYBX) markets.businessinsider.com - August 11 at 6:40 PMWebDec 18, 2022 · Conestoga Capital Advisors highlighted stocks like BioLife Solutions, Inc. (NASDAQ:BLFS) in its Q3 2022 investor letter. Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS ...

BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ...WebJan 5, 2023 · First, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ...

The deal is an all-stock transaction that will grow BioLife Solutions revenue by 80% by the end of the year with accretive impact to bottom-line results in 2022. The upgrade comes from Benchmark and is from Neutral to Buy. The price target is $54 or 40% from upside from Monday’s close but don’t rush to buy just yet.WebBLFS Stock 12 Months Forecast. $23.25. (128.61% Upside) Based on 6 Wall Street analysts offering 12 month price targets for BioLife Solutions in the last 3 months. The average price target is $23.25 with a high forecast of $26.00 and a low forecast of $20.00. The average price target represents a 128.61% change from the last price of $10.17.Get the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's performance outlook, earnings date, dividend and yield, fair value, ratings and more.Jun 26, 2020 · BLFS. BioLife Solutions, Inc. 11.83. +1.05. +9.74%. The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of ... Notes to Financial Statements Business Combination Disclosure [Text Block] 15. Acquisitions Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in …Sep 2, 2022 · Biolife Keto Gummies helps in boosting your immunity and digestion power and makes you becomes healthy and fit in short period of time. Thursday, Nov 30, 2023 Login BANNOCKBURN, Ill., March 27, 2023--BioLife Plasma Services, part of the global biopharmaceutical company Takeda, today announced the opening of its 200th plasma donation center in the United ...WebEvogene Ltd. -0.32%. $32.76M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...Web

Biolife Stock Ipo: Can You Buy Stock In This Plasma Company? It’s a captivating David vs. Goliath story, where David — at least on some fronts — appears to be winning. When a stock goes ex-dividend, the value of that stock effectively falls by the dividend amount. This means if you hold a spread bet or CFD position on a company …

Nov 30, 2023 · See the latest BioLife Solutions Inc stock price (BLFS:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Thinly traded micro cap BioLife Solutions (NASDAQ:BLFS -15.6%) has increased its stake in SAVSU Technologies to 44% with a $5M investment.Evogene Ltd. -0.32%. $32.76M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. In Stock . Qty: Qty: 1 $ $18.99 18. 99 () Includes selected options. Includes initial monthly payment and selected options. ... and herbs. Biolife provides the perfect amount of vitamins, minerals, antioxidants, and herbs. Biolife helps to bridge the nutrient gap in your diet. It offers immune support, increased energy, and mental alertness by ...Nov 29, 2023 · BioLife was founded as Trans Time Medical Products in 1987 and went public in 1989, raising net proceeds of $4.6 million at $105 per share (after giving effect to 1-for-five (2000) and 1-for-14 ... biolife sciences inc. biolife sciences inc. 0.00 ‎-11.11% 0.0004Mar 2, 2023 · BOTHELL - BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ('CGT') and broader biopharma markets, today announced the launch of Ultraguard, the first ever non-toxic, non-hazardous and non-flammable -70-degreeC phase change material ('PCM'), for ultra-low temperature (ULT) protection. BioLife Solutions, Inc. announced that it has entered into a Securities Purchase Agreement with returning investor, Casdin Partners Master Fund, L.P. managed by Casdin Capital, LLC that it has issued 927,165 shares of common stock of the Company, par value $0.001 per share at a purchase price of $11.19 per share for an aggregate gross proceeds ...Get the latest Biolife Sciences Inc (BLFE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...WebStock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Aug 9, 2021 · BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has entered into a definitive agreement to acquire all remaining outstanding shares of privately held Sexton ... Biolife Solutions Working Capital is currently at 5.25 M. Working Capital is a measure of Biolife Solutions efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .Instagram:https://instagram. nyse feardx stock forecastcramers mad moneybest application for stock market BioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …20 ก.ย. 2565 ... Cryoport probably gets the edge thanks to its larger size and international presence. While it also has a better (not great) gross margin, ... vgt portfoliois verses ai a good investment Story continues Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of … stock trading software BLFS: Raising target price to $11.00BIOLIFE SOLUTIONS INC has an Investment Rating of SELL; a target price of $11.000000; an Industry Subrating of Low; a Management …BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of Sexton Biotechnologies.